You are here

ProQR

After February market crash, ProQR will lay off 30% of its workforce and try pushing eye therapy after failed trial

Endpoints

Wed, 04/13/22 - 10:46 am

What Vertex’s Results Mean for Corbus, ProQR, and Nivalis

Yahoo

Tue, 02/16/16 - 07:41 pm

Vertex Pharmaceuticals

2014's most successful biotech IPOs

Fierce Biotech

Mon, 10/13/14 - 08:03 am

Auspex Pharmaceuticals

Avalanche Biotechnologies

SAGE Therapeutics

CF biotech ProQR shoots for a $75M IPO to challenge Vertex

Fierce Biotech

Fri, 08/15/14 - 11:49 am

cystic fibrosis

Vertex Pharmaceuticals